Healthcare and Life Science
An industry agenda for advanced therapies
11 priorities for building scalable and accessible advanced therapies.
2026 Nominations window opens for #21toWatch Innovation Awards: “Celebrating what’s new and amplifying what’s next”
We are delighted to announce that the 2026 nominations/applications window for the #21toWatch innovation awards is now open. ...
The Cambridge Phenomenon continues to intensify and spread out into new locations as businesses double down on clustering to succeed
Cambridge Ahead published new research, undertaken by the Centre for Business Research (CBR), taking a deep dive look at clusters in the Cambridge city region economy over the last decade. The research highlights the phenomenal growth of the Cambridge economy, far outpacing the national...
FairJourney Biologics appoints Dr. Werner Lanthaler as Chief Executive Officer
Dr. Werner Lanthaler will strengthen FairJourney Biologics’ global position as a highly efficient partner for antibody discovery and developmentFounder António Parada will focus on innovation strategy on the Supervisory BoardPORTO, Portugal, 08 October, 2025 – FairJourney Biologics S.A....
SPT Labtech and Agilent introduce automated target enrichment protocols for genomic workflows
Optimized, automated protocols on SPT Labtech’s firefly®+ using Agilent’s SureSelect Max DNA Library Prep KitSupports high-throughput sequencing in clinical research, oncology, and precision medicineProtocols to be showcased at ASHG, 14th – 18th October, Boston, MACambridge, UK, 08 Octo...
Qkine launches cell therapy grade recombinant proteins to support next-generation therapies
Cambridge, UK – Qkine, Ltd., a specialist bioactive protein manufacturer with its core technology developed at the University of Cambridge, today announced the launch of its Cell Therapy Grade proteins, engineered to support the stringent requirements of cell therapy research, process d...
Book Launch: 'The Imposter Phenomenon, why you feel like a fraud and what to do about it' is out now
Research indicates that 70-80% of people may experience imposter “syndrome” at some point. Celebrities such as Michelle Obama, Sheryl Sandberg and Tom Hanks have all spoken about their imposter feelings and even Einstein described himself as an “involuntary swindler”. But self-doubt and...
Owlstone Medical wins up to $49.1 million award from ARPA-H to develop at-home multi-cancer-early detection tests
Goal of POSEIDON is to enable accurate, low-cost, accessible cancer screening for all AmericansProgram to deliver first-in-class synthetic-sensor based MCED test for Stage I detection of 30+ solid tumorsOwlstone to work in partnership with the Massachusetts Institute of Technology, Bost...
Guardtech open partnership with Dry Air to offer game-changing dry room facility installations for Battery industry and beyond
Suffolk-based cleanroom construction specialists the Guardtech Group are set to combine their envelope knowhow with Dry Air’s groundbreaking sealing techniques and HVAC expertise ...
The 15-year warning: Why we need to measure lung decline in traffic jams, not clinic waiting rooms
Insights from Bipin Patel, CEO & Founder